BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 19648470)

  • 1. (R)-(3-amino-2-fluoropropyl) phosphinic acid (AZD3355), a novel GABAB receptor agonist, inhibits transient lower esophageal sphincter relaxation through a peripheral mode of action.
    Lehmann A; Antonsson M; Holmberg AA; Blackshaw LA; Brändén L; Bräuner-Osborne H; Christiansen B; Dent J; Elebring T; Jacobson BM; Jensen J; Mattsson JP; Nilsson K; Oja SS; Page AJ; Saransaari P; von Unge S
    J Pharmacol Exp Ther; 2009 Nov; 331(2):504-12. PubMed ID: 19648470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel, peripherally restricted GABAB receptor agonist lesogaberan (AZD3355) inhibits acid reflux and reduces esophageal acid exposure as measured with 24-h pHmetry in dogs.
    Brändén L; Fredriksson A; Harring E; Jensen J; Lehmann A
    Eur J Pharmacol; 2010 May; 634(1-3):138-41. PubMed ID: 20176012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of (2R)-(3-amino-2-fluoropropyl)sulphinic acid (AFPSiA) on transient lower oesophageal sphincter relaxation in dogs and mechanism of hypothermic effects in mice.
    Lehmann A; Holmberg AA; Bhatt U; Bremner-Danielsen M; Brändén L; Elg S; Elebring T; Fitzpatrick K; Geiss WB; Guzzo P; Jensen J; Jerndal G; Mattsson JP; Nilsson K; Olsson BM
    Br J Pharmacol; 2005 Sep; 146(1):89-97. PubMed ID: 15980875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GABAB receptor agonism as a novel therapeutic modality in the treatment of gastroesophageal reflux disease.
    Lehmann A; Jensen JM; Boeckxstaens GE
    Adv Pharmacol; 2010; 58():287-313. PubMed ID: 20655487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel treatments of GERD: focus on the lower esophageal sphincter.
    Lehmann A
    Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():103-10. PubMed ID: 18924449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and pharmacological evaluation of novel gamma-aminobutyric acid type B (GABAB) receptor agonists as gastroesophageal reflux inhibitors.
    Alstermark C; Amin K; Dinn SR; Elebring T; Fjellström O; Fitzpatrick K; Geiss WB; Gottfries J; Guzzo PR; Harding JP; Holmén A; Kothare M; Lehmann A; Mattsson JP; Nilsson K; Sundén G; Swanson M; von Unge S; Woo AM; Wyle MJ; Zheng X
    J Med Chem; 2008 Jul; 51(14):4315-20. PubMed ID: 18578471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lesogaberan, a GABA(B) agonist for the potential treatment of gastroesophageal reflux disease.
    Bredenoord AJ
    IDrugs; 2009 Sep; 12(9):576-84. PubMed ID: 19697277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of lesogaberan, a novel GABA(B)-receptor agonist, on transient lower oesophageal sphincter relaxations in male subjects.
    Boeckxstaens GE; Rydholm H; Lei A; Adler J; Ruth M
    Aliment Pharmacol Ther; 2010 Jun; 31(11):1208-17. PubMed ID: 20222915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translational gastrointestinal pharmacology in the 21st century: 'the lesogaberan story'.
    Boeckxstaens GE; Denison H; Jensen JM; Lehmann A; Ruth M
    Curr Opin Pharmacol; 2011 Dec; 11(6):630-3. PubMed ID: 22036168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The GABA(B) antagonist CGP56433A attenuates the effect of baclofen on cocaine but not heroin self-administration in the rat.
    Brebner K; Froestl W; Roberts DC
    Psychopharmacology (Berl); 2002 Feb; 160(1):49-55. PubMed ID: 11862373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of GABA(B) receptors by chronic administration of the GABA(B) receptor antagonist SCH 50,911.
    Pibiri F; Carboni G; Carai MA; Gessa GL; Castelli MP
    Eur J Pharmacol; 2005 May; 515(1-3):94-8. PubMed ID: 15893746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GABA(B) receptor-activation inhibits GABAergic synaptic transmission in parvocellular neurones of rat hypothalamic paraventricular nucleus.
    Liu X; Tribollet E; Raggenbass M
    J Neuroendocrinol; 2006 Mar; 18(3):177-86. PubMed ID: 16454801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond acid suppression: new pharmacologic approaches for treatment of GERD.
    Kuo P; Holloway RH
    Curr Gastroenterol Rep; 2010 Jun; 12(3):175-80. PubMed ID: 20425477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The GABA(B) receptor agonist AZD9343 inhibits transient lower oesophageal sphincter relaxations and acid reflux in healthy volunteers: a phase I study.
    Beaumont H; Smout A; Aanen M; Rydholm H; Lei A; Lehmann A; Ruth M; Boeckxstaens G
    Aliment Pharmacol Ther; 2009 Nov; 30(9):937-46. PubMed ID: 19650825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of gamma-aminobutyric acid receptor type B receptors and calcium channels in nociceptive transmission studied in the mouse hemisected spinal cord in vitro: withdrawal symptoms related to baclofen treatment.
    Dang K; Bowery NG; Urban L
    Neurosci Lett; 2004 May; 361(1-3):72-5. PubMed ID: 15135896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reflux inhibitors: a new approach for GERD?
    Boeckxstaens GE
    Curr Opin Pharmacol; 2008 Dec; 8(6):685-9. PubMed ID: 18771751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of GABA(B) receptor agonist on distension-sensitive pelvic nerve afferent fibers innervating rat colon.
    Sengupta JN; Medda BK; Shaker R
    Am J Physiol Gastrointest Liver Physiol; 2002 Dec; 283(6):G1343-51. PubMed ID: 12388205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different in vitro and in vivo profiles of substituted 3-aminopropylphosphinate and 3-aminopropyl(methyl)phosphinate GABA(B) receptor agonists as inhibitors of transient lower oesophageal sphincter relaxation.
    Lehmann A; Antonsson M; Aurell-Holmberg A; Blackshaw LA; Brändén L; Elebring T; Jensen J; Kärrberg L; Mattsson JP; Nilsson K; Oja SS; Saransaari P; von Unge S
    Br J Pharmacol; 2012 Mar; 165(6):1757-1772. PubMed ID: 21950457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of GABA agonists on body temperature regulation in GABA(B(1))-/- mice.
    Quéva C; Bremner-Danielsen M; Edlund A; Ekstrand AJ; Elg S; Erickson S; Johansson T; Lehmann A; Mattsson JP
    Br J Pharmacol; 2003 Sep; 140(2):315-22. PubMed ID: 12970075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologically distinct GABAB receptors that mediate inhibition of GABA and glutamate release in human neocortex.
    Bonanno G; Fassio A; Schmid G; Severi P; Sala R; Raiteri M
    Br J Pharmacol; 1997 Jan; 120(1):60-4. PubMed ID: 9117099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.